Replies to post #66463 on Biotech Values

[masterlongevity]

this is an area i'm surprised tysabri hasn't been tested in. i sometimes wonder what the heck biogen and elan are doing in terms of continued development.

no head to head trials
no new indication trials
no switching trials
no earlier line trials

[genisi]

Teva/Copaxone Data in CIS

PreCISe data published in the Lancet #msg-42284652